Evidence map›Paper›PMID 35310821›Full record

ArticleAdvanced therapeutics2022

Inhibition of Collagenase Q1 of

Alaa Alhayek, Essak S Khan, Esther Schönauer, Tobias Däinghaus, Roya Shafiei, Katrin Voos, Mitchell K L Han, Christian Ducho, Gernot Posselt, Silja Wessler and 4 more

Open access · hybridAbstract read
In one paragraph

Article in Advanced therapeutics, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.8field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 4 institutions in 2 countries.

Alaa AlhayekHelmholtz Institute for Pharmaceutical Research Saarland (HIPS) Helmholtz Centre for Infection Research (HZI) 38124 Saarbrücken, Germany; Department of Pharmacy Saarland University, Saarbrücken Campus Campus E8.1, 66123 Saarbrücken, Germany.
Essak S KhanLeibniz Institute for New Materials (INM) Saarland University Campus D2 2, 66123 Saarbrücken, Germany.
Esther SchönauerDepartment of Biosciences and Medical Biology Hellbrunner Str. 34 University of Salzburg Salzburg 5020, Austria.
Tobias DäinghausLeibniz Institute for New Materials (INM) Saarland University Campus D2 2, 66123 Saarbrücken, Germany.
Roya ShafieiHelmholtz Institute for Pharmaceutical Research Saarland (HIPS) Helmholtz Centre for Infection Research (HZI) 38124 Saarbrücken, Germany.
Katrin VoosDepartment of Pharmacy Pharmaceutical and Medicinal Chemistry Saarland University Campus C2 3, 66123 Saarbrücken, Germany.
Mitchell K L HanLeibniz Institute for New Materials (INM) Saarl and University Campus D2 2, 66123 Saarbrücken, Germany.
Christian DuchoDepartment of Pharmacy Pharmaceutical and Medicinal Chemistry Saarland University Campus C2 3, 66123 Saarbrücken, Germany.
Gernot PosseltDepartment of Biosciences and Medical Biology Hellbrunner Str. 34 University of Salzburg Salzburg 5020, Austria.
Silja WesslerDepartment of Biosciences and Medical Biology Hellbrunner Str. 34 University of Salzburg Salzburg 5020, Austria.
Hans BrandstetterDepartment of Biosciences and Medical Biology Hellbrunner Str. 34 University of Salzburg Salzburg 5020, Austria.
Jörg HaupenthalHelmholtz Institute for Pharmaceutical Research Saarland (HIPS) Helmholtz Centre for Infection Research (HZI) 38124 Saarbrücken, Germany.
Aránzazu Del CampoLeibniz Institute for New Materials (INM) Saarland University Campus D2 2, 66123 Saarbrücken, Germany; Chemistry Department Saarland University 66123 Saarbrücken, Germany.
Anna K H HirschHelmholtz Institute for Pharmaceutical Research Saarland (HIPS) Helmholtz Centre for Infection Research (HZI) 38124 Saarbrücken, Germany; Department of Pharmacy Saarland University, Saarbrücken Campus Campus E8.1, 66123 Saarbrücken, Germany.
Helmholtz Centre for Infection Research · DELeibniz-Institute for New Materials · DEUniversity of Salzburg · ATSaarland University · DE

Funding

Austrian Science Fund FWF I 4360Austrian Science Fund FWF P 31843
6 · The paper itself

Abstract

Despite the progress in surgical techniques and antibiotic prophylaxis, opportunistic wound infections with

Indexed as

antibiotic resistanceBacillus cereuscollagenasepathoblockervirulence factors

Identifiers

PMID35310821
PMCPMC7612511
OpenAlexW4206509277

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.